Symptoms of Anxiety and Depression Among Slovenian Breast Cancer Survivors Post-Treatment During the COVID-19 Pandemic: A Cross-Sectional Study

Author:

MIROŠEVIČ Špela12ORCID,PRINS Judith3,BEŠIĆ Nikola4ORCID,BORŠTNAR Simona5ORCID,ŠKUFCA SMRDEL Andreja Cirila6,HOMAR Vesna1ORCID,POPOVIĆ Marko1,KLEMENC-KETIŠ Zalika127ORCID

Affiliation:

1. 1 University of Ljubljana, Faculty of Medicine, Department of Family Medicine , Poljanski nasip 58 , Ljubljana , Slovenia

2. 2 Community Health Centre Ljubljana , Metelkova 9 , Ljubljana , Slovenia

3. 3 Radboud University Medical Centre, Department of Medical Psychology , Nijmegen , Netherlands

4. 4 Institute of Oncology, Department of Surgical Oncology Ljubljana , Zaloška 2 , Ljubljana , Slovenia

5. 5 Institute of Oncology, Department of Medical Oncology Ljubljana , Zaloška 2 , Ljubljana , Slovenia

6. 6 Institute of Oncology Ljubljana, Department of Psycho-Oncology , Zaloška 2 , Ljubljana , Slovenia

7. 7 University of Maribor, Faculty of Medicine, Department of Family Medicine , Taborska 8 , Maribor , Slovenia

Abstract

ABSTRACT Background Although anxiety and depression are important determinants of mental health, the literature in this area is sparse as most studies focus on the period during treatment. Mental health problems can affect cancer recovery as well as quality of life and survival. In this cross-sectional study, we investigated the prevalence of anxiety and depression in Slovenian cancer survivors after treatment and assessed the associated correlates during the COVID-19 pandemic. Methods From September 2021 to January 2022, we collected data from 430 breast cancer survivors one to five years after receiving post-local treatment and (neo)adjuvant chemotherapy. We used the Hospital Anxiety and Depression Scale (HADS) to measure anxiety and depression levels. Multivariate linear regression was used to identify factors associated with higher levels of anxiety and depression. Results Key findings from this study are increased levels of psychological distress and identification of relevant factors associated with those elevated levels. Approximately one-third of breast cancer survivors exhibited symptoms of elevated anxiety and depression, with one in eight meeting clinical thresholds. Multivariate linear regression revealed that age, lower quality of life, heightened fear of cancer recurrence (FCR), reduced resilience, limited social support, and unmet psychosocial and emotional needs correlated with increased anxiety symptoms. Additionally, lower quality of life, higher FCR, diminished resilience, and limited social support were associated with higher depression symptomatology. Conclusions Our study of Slovenian breast cancer survivors one to five years post-treatment observed a significant increase in anxiety and depression symptoms, possibly exacerbated by the COVID-19 pandemic. The demographic and psychosocial factors identified in this study offer valuable insights for future research. The study emphasises the importance of recognising and addressing the psychological needs of breast cancer survivors and the need to follow them throughout their cancer journey.

Publisher

Walter de Gruyter GmbH

Subject

Public Health, Environmental and Occupational Health

Reference46 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660.

2. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023-1075. doi: 10.1016/ S0140-6736(17)33326-3.

3. The organization for economic cooperation and development. EU Country Cancer Profile: Slovenia 2023, EU Country Cancer Profiles. [Internet]. 2023 [cited 2023 Sept 22]. Available from: https://www. gov.si/assets/ministrstva/MZ/DOKUMENTI/DJZ-Preventiva-in-skrb-za-zdravje/nenalezljive-bolezni/DPOR-2022-2026/Country-Cancer-Profile-Slovenija-OECD-in-EK-2023.pdf

4. Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018;361:k1415. doi: 10.1136/bmj.k1415.

5. Wu HS, Harden JK. Symptom burden and quality of life in survivorship: A review of the literature. Cancer Nurs. 2015;38(1):E29-E54. doi: 10.1097/NCC.0000000000000135.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3